Physician profile
Daniel Walter Kaiser
NPI 1972777480
$25,824.98
in general payments reported to CMS, 2019-2025
23 companies · $4,597 in 2025
The $4,597 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,443 · 2020: $1,047 · 2021: $4,139 · 2022: $2,323 · 2023: $2,883 · 2024: $5,393 · 2025: $4,597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,094 · Travel and Lodging: $3,779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,094.08 |
| Travel and Lodging | $3,778.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $14,110.05 | 2019-2025 | Farapulse, Watchman Access System, Watchman Flx |
| Abbott Laboratories | $7,506.58 | 2019-2025 | Ensite Precision, Thoratec Heartmate 3 Lvas Implant Kit, Ensite |
| Medtronic, INC. | $1,665.97 | 2021-2025 | Micra, Arctic Front Advance, Cobalt Dr Mri Surescan |
| Janssen Pharmaceuticals, INC | $732.60 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $588.87 | 2019 | |
| Novo Nordisk INC | $258.91 | 2022-2024 | Wegovy, Ozempic, Rybelsus |
| Biotronik INC. | $219.13 | 2019 | |
| Heartflow, INC. | $123.78 | 2024 | |
| Cardiofocus, INC. | $118.11 | 2019 | |
| Biosense Webster, INC. | $113.38 | 2023 | Carto 3, Nuvision Ice Catheter, Soundstar |
| Bardy Diagnostics, INC. | $63.63 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.15 | 2023-2024 | Jardiance |
| Elutia, INC. | $51.03 | 2022-2023 | |
| Scpharmaceuticals INC. | $32.38 | 2023-2024 | |
| Actelion Pharmaceuticals US, INC. | $30.09 | 2024 | Opsumit, Uptravi |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $27.62 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.41 | 2023 | Lifevest |
| Braemar Manufacturing, LLC | $21.55 | 2019 | |
| Atricure, INC. | $20.49 | 2025 | Atriclip Laa Exclusion System |
| Astrazeneca Pharmaceuticals LP | $19.71 | 2024 | Farxiga |
| Sanofi-Aventis U.S. LLC | $14.00 | 2023 | |
| Amgen INC. | $13.98 | 2019 | |
| Corcept Therapeutics | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kaiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.